The iconic Asian startup exhibition, InnoVEX 2023, was held from May 30th to June 2nd at Taipei Nangang Exhibition Center. Many international startups registered for InnoVEX 2023 startup competition, known as the InnoVEX Pitch Contest. 35% of the registered startups were from a total of 12 countries/areas, including Japan, Hong Kong, Italy, US, Brazil, Canada, South Korea, Chile, Egypt, Germany, and India. From the 80 participants, 10 startups were selected to proceed to the final stage to compete for the prizes with a total value of USD 120,000. BELX Bio-pharmaceutical with its core expertise in developing botanical new drug, was selected as one of the top ten finalists and competed in the finals held on June 2nd.
InnoVEX https://www.innovex.com.tw/en/news/B7816291C5FB3643/info.html
Copyright (c) 2020 BELX Bio-Pharmaceutical (Taiwan) Corporation. All rights reserved